Headache

Papers
(The H4-Index of Headache is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report463
Erratum80
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin72
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine70
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma68
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study67
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study62
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA59
Migraine and peripheral pain models show differential alterations in neuronal complexity53
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space51
A retrospective analysis of the use of candesartan for migraine prevention in adolescents50
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample47
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment44
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache43
Post‐traumatic headache: An unmet medical need42
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine40
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine37
Migraine screening in English and Spanish34
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes 32
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers31
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine29
Patient preference for early onset of efficacy of preventive migraine treatments28
Sex and gender: Opportunities to expand research and understanding within headache medicine28
Prevalence of primary stabbing headache: A meta‐analysis28
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study27
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine27
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl26
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa26
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study26
0.41488194465637